1. Home
  2. SNY vs MELI Comparison

SNY vs MELI Comparison

Compare SNY & MELI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • MELI
  • Stock Information
  • Founded
  • SNY 1994
  • MELI 1999
  • Country
  • SNY France
  • MELI Uruguay
  • Employees
  • SNY N/A
  • MELI N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • MELI Catalog/Specialty Distribution
  • Sector
  • SNY Health Care
  • MELI Consumer Discretionary
  • Exchange
  • SNY Nasdaq
  • MELI Nasdaq
  • Market Cap
  • SNY 113.4B
  • MELI 124.4B
  • IPO Year
  • SNY N/A
  • MELI 2007
  • Fundamental
  • Price
  • SNY $46.97
  • MELI $2,446.32
  • Analyst Decision
  • SNY Buy
  • MELI Strong Buy
  • Analyst Count
  • SNY 4
  • MELI 19
  • Target Price
  • SNY $61.50
  • MELI $2,792.63
  • AVG Volume (30 Days)
  • SNY 2.7M
  • MELI 363.6K
  • Earning Date
  • SNY 10-24-2025
  • MELI 11-05-2025
  • Dividend Yield
  • SNY 3.40%
  • MELI N/A
  • EPS Growth
  • SNY 118.56
  • MELI 46.70
  • EPS
  • SNY 8.65
  • MELI 40.49
  • Revenue
  • SNY $53,714,621,258.00
  • MELI $24,096,000,000.00
  • Revenue This Year
  • SNY $1.53
  • MELI $37.26
  • Revenue Next Year
  • SNY $7.06
  • MELI $25.78
  • P/E Ratio
  • SNY $5.43
  • MELI $60.37
  • Revenue Growth
  • SNY 15.65
  • MELI 35.81
  • 52 Week Low
  • SNY $44.73
  • MELI $1,646.00
  • 52 Week High
  • SNY $60.12
  • MELI $2,645.22
  • Technical
  • Relative Strength Index (RSI)
  • SNY 43.02
  • MELI 58.14
  • Support Level
  • SNY $46.50
  • MELI $2,290.50
  • Resistance Level
  • SNY $47.69
  • MELI $2,402.89
  • Average True Range (ATR)
  • SNY 0.68
  • MELI 67.86
  • MACD
  • SNY -0.18
  • MELI 2.22
  • Stochastic Oscillator
  • SNY 36.14
  • MELI 72.86

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

About MELI MercadoLibre Inc.

MercadoLibre runs the largest e-commerce marketplace in Latin America, with more than 218 million active users and 1 million active sellers across 18 countries stitching into its commerce network or fintech solutions when last reported. The company operates a host of complementary businesses to its core online shop, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago and Mercado Credito), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.

Share on Social Networks: